Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine as Adjunctive Therapy in Schizophrenia
NCT03548155Completed
- Sponsor
- Tianjin Anding Hospital
- Start
- Jul 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of berberine in schizophrenia (2 arms), sponsored by Tianjin Anding Hospital. Primary endpoint: Changes of negative symptoms at 8 weeks. Started Jul 2014; status: completed.
02
Drugs
berberine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03548155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548155.